Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
AT&T (United States) · University of Manitoba · +3 more institutions
Indexed incrossrefpubmed
Abstract
Objective
The aim was to determine the effects of prior denosumab or placebo injections on BMD, BTM, and safety over 24 months after treatment discontinuation.
Design
We conducted an off-treatment extension of a phase 3, randomized, double-blind, parallel-group study.
Citation impact
607
total citations
- FWCI
- 22.80
- Percentile
- 100%
- References
- 34
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- N-terminal telopeptide
- Medicine
- Denosumab
- Discontinuation
- Bone mineral
- Bone remodeling
- Placebo
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.